Rhythm Pharmaceuticals Headquarters
Looking for information about Rhythm Pharmaceuticals Headquarters? The links below have collected all the necessary data.
Home - Rhythm Pharmaceuticals
- https://www.rhythmtx.com/
- Rhythm Pharmaceuticals to Present at Morgan Stanley 19th Annual Global Healthcare Conference. Read More. 2021-08-12T07:45:00. Rhythm Pharmaceuticals to Present at the 59th Annual ESPE Meeting. Read More. More News. RHYTHM Contact Us Rhythm Pharmaceuticals, Inc. 222 Berkeley Street, 12th Floor
Rhythm Pharmaceuticals Company Profile Management and ...
- https://www.datanyze.com/companies/rhythm-pharmaceuticals/346201213
- Headquarters. 222 Berkeley St, Ste 1200, Boston, Massachusetts, 02116, United States (857) 264-4280. ... Rhythm Pharmaceuticals Profile and History . Rhythm is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare genetic disorders of obesity. The Company is developing ...Employees: 54
Rhythm Pharmaceuticals Company Profile - Office Locations ...
- https://craft.co/rhythm-pharmaceuticals-811
- Jul 29, 2021 · Rhythm Pharmaceuticals has 22 employees. Who are Rhythm Pharmaceuticals competitors? Competitors of Rhythm Pharmaceuticals include YiChang HEC ChangJiang Pharmaceutical, Cadila Pharmaceuticals and Biogen. Where is Rhythm Pharmaceuticals headquarters? Rhythm Pharmaceuticals headquarters is located at 222 Berkeley St # 12, Boston.Employees: 22
Contact Rhythm Pharmaceuticals
- https://www.rhythmtx.com/contact-us/
- Rhythm Pharmaceuticals, Inc. 222 Berkeley Street, 12th Floor Boston, MA 02116. phone 857-264-4280. fax 857-264-4299. Follow us.
Investor Overview Rhythm Pharmaceuticals, Inc.
- https://ir.rhythmtx.com/investor-overview
- Aug 05, 2021 · Rhythm Pharmaceuticals, Inc. was founded in February 2008. Where is Rhythm headquartered? Rhythm is headquartered at 222 Berkeley Street, 12th Floor, Boston, MA 02116. On which stock exchange are Rhythm shares traded, what is the ticker symbol, and when did it go public? Rhythm’s stock is traded on the NASDAQ Global Market under the symbol RYTM.
Rhythm Headquarters - Charles Rose Architects
- https://archive.charlesrosearchitects.com/projects/rhythm-pharmaceuticals/
- Scope: Headquarters for biopharmaceutical company Rhythm Pharmaceuticals is a Boston-based biopharmaceutical company focused on developing drugs for the treatment of rare genetic obesity disorders. After experiencing rapid growth, catalyzed by the success of a new breakthrough drug, Charles Rose Architects assisted Rhythm in selecting a new ...
Rhythm Pharmaceuticals - Crunchbase Company Profile & …
- https://www.crunchbase.com/organization/rhythm-pharmaceuticals-2
- Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. Their lead peptide product candidate, setmelanotide, is a potent, first-in-class melanocortin-4 receptor (MC4R) agonist for the treatment of rare.
Rhythm Pharmaceuticals - Overview, News & Competitors ...
- https://www.zoominfo.com/c/rhythm-pharmaceuticals-inc/346201213
- Rhythm Pharmaceuticals to Present at 2021 Canaccord Genuity 41st Annual Growth Conference BOSTON, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced that David Meeker, M.D., Chair, President and Chief …Employees: 54
Rhythm Pharmaceuticals Inc. LinkedIn
- https://www.linkedin.com/company/rhythm-pharmaceuticals-inc-
- Rhythm Pharmaceuticals Inc. 10,405 followers on LinkedIn. Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of ...Founded: 2008
Our Management - Rhythm Pharmaceuticals
- https://www.rhythmtx.com/management
- Rhythm is a biopharmaceutical company dedicated to changing how rare genetic diseases of obesity are diagnosed and treated.. Disorders of severe obesity may result from genetic variants within the melanocortin-4 receptor (MC4R) pathway, a key pathway responsible for regulating weight, that lead to excessive or insatiable hunger or hyperphagia.
Have you found Rhythm Pharmaceuticals Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.